Drug used for breast, kidney cancers may also extend survival for head and neck cancers
A targeted therapy drug used for breast and kidney cancers may also extend progression-free survival for patients with advanced head and neck cancer who are at high risk for recurrence after standard treatment. Patients enrolled ...
Feb 27, 2020
0
0